Immune Responses Similar for Adjuvanted and Standard Dose Influenza Vaccines for Patients with Haematologic Malignancies By Ogkologos - February 4, 2025 744 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a randomised, controlled study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Ralph, Medical Dog, Retires From Colorado Children’s Hospital To Focus On... July 29, 2021 Young District Attorney Diagnosed with Breast Cancer Encourages Others to Get... November 30, 2020 ESMO Gynaecological Cancers Congress 2022, 17 – 18 June 2022 Valencia,... June 2, 2022 A toolkit to address disparities in digitally enabled oncology trials September 5, 2025 Load more HOT NEWS Pazopanib Shows Promise for Children, Adults with Soft Tissue Sarcomas Is a Genomic Test Better at Finding Aggressive Prostate Cancer? Benefit of Adjuvant Capecitabine After Curative Resection of Biliary Tract Cancer... Optimistic targets aren’t enough – this is what we need to...
